ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Research body recommends COVID-19 drug
August 02, 2021Australia's National COVID-19 Clinical Evidence Taskforce issued a new recommendation conditionally backing use of Regeneron's COVID-19 antibody cocktail REGEN-COV (casirivimab/imdevimab), as reported Sunday in This is Money. -
Regeneron Starts Phase 3 Trial for Coronavirus Antibody Cocktail
July 07, 2020Anti-viral antibody cocktail REGN-COV2 is also in Phase 2/3 treatment trials following positive Phase 1 safety review. -
Regeneron Begins Trials of Anti-Viral Antibody Cocktail for COVID-19
June 22, 2020Regeneron Pharmaceuticals announced initiation of the first clinical trial of REGN-COV2, its investigational dual antibody cocktail for the prevention and treatment of COVID-19.
Pharma Sources Insight January 2025
